Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT01762046
PHASE1

Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans

Sponsor: Massachusetts General Hospital

View on ClinicalTrials.gov

Summary

The SUGAR-MGH investigators are studying the influence of inherited gene variants on the response to two commonly prescribed type 2 diabetes medications, metformin and glipizide. They hypothesize that variants in genes that are associated with type 2 diabetes or related traits may impact the effect of anti-diabetic medications. In addition, physiological responses to an insulin secretagogue or an insulin sensitizer may shed light on the mechanism of action of reported genetic associations.

Key Details

Gender

All

Age Range

18 Years - 85 Years

Study Type

INTERVENTIONAL

Enrollment

1033

Start Date

2008-01

Completion Date

2025-12

Last Updated

2025-05-08

Healthy Volunteers

Yes

Interventions

DRUG

Glipizide

DRUG

Metformin

OTHER

Oral Glucose Tolerance Test

Locations (3)

Massachusetts General Hospital

Boston, Massachusetts, United States

Brigham and Women's Hospital

Boston, Massachusetts, United States

Joslin Diabetes Center

Boston, Massachusetts, United States